One way to arrest cancer is to identify a molecule that malignant cells just can’t do without—and then disable it. Researchers now report success with two experimental drugs that target such a protein, which triggers rapid growth and other malignant changes in cancer cells.
In mice, one of the drugs slows multiple myeloma, a lethal bone marrow cancer, and the other limits fibrosarcoma, a tumor of fibrous tissues.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.